Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F
Inventiva S.A. - American Depository Shares (IVA)
Company Research
Source: GlobeNewswire
Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that it had filed its 2025 Universal Registration Document for the year ended December 31, 2025, including the management report and the annual financial report, with the French Autorité des Marchés Financiers (“AMF”) and its 2025 Annual Report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”). These documents can be accessed on the “Investors” section of the Company’s corporate website (www.inventivapharma.com). In addition, the 2025 Universal Registration Document is available on the website of the AMF (www.amf-france.org) and the 2025 Annual Report on Form 20-F is also available on the website ofthe SEC (www.sec.go
Show less
Read more
Impact Snapshot
Event Time:
IVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IVA alerts
High impacting Inventiva S.A. - American Depository Shares news events
Weekly update
A roundup of the hottest topics
IVA
News
- Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of LanifibranorGlobeNewswire
- Inventiva (IVA) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IVA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "sellMarketBeat
- Inventiva reports 2025 full year results and provides a business updateGlobeNewswire
- Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results GlobeNewswire
- Inventiva (IVA) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
IVA
Earnings
- 3/30/26 - Miss
IVA
Sec Filings
- 4/22/26 - Form 6-K
- 4/8/26 - Form 20-F
- 4/1/26 - Form SCHEDULE
- IVA's page on the SEC website